TransMedics Group (NASDAQ:TMDX) reported its Q2 earnings results on Monday, August 1, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
TransMedics Group missed estimated earnings by 17.14%, reporting an EPS of $-0.41 versus an estimate of $-0.35.
Revenue was up $12.35 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 40.33% increase in the share price the next day.
Here’s a look at TransMedics Group’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.38 | -0.42 | -0.36 | -0.28 |
| EPS Actual | -0.38 | -0.46 | -0.47 | -0.39 |
| Revenue Estimate | 9.65M | 7.52M | 6.35M | 7.80M |
| Revenue Actual | 15.88M | 9.67M | 5.37M | 8.17M |
To track all earnings releases for TransMedics Group visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
